Duopharma said on Monday the government had written to Biocon Sdn Bhd and the company about the amendments to the January 2017 agreement which included an extension to supply the insulin.
KUALA LUMPUR: Duopharma Biotech Bhd
had its contract to supply human insulin product to the government extended by one year to Dec 1,2020 with an additional contract value of RM91.06mil.
It said on Monday the government had written to Biocon Sdn Bhd and the company about the amendments to the January 2017 agreement which included an extension to supply the insulin.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
